331 related articles for article (PubMed ID: 25241065)
21. Opioid activation of toll-like receptor 4 contributes to drug reinforcement.
Hutchinson MR; Northcutt AL; Hiranita T; Wang X; Lewis SS; Thomas J; van Steeg K; Kopajtic TA; Loram LC; Sfregola C; Galer E; Miles NE; Bland ST; Amat J; Rozeske RR; Maslanik T; Chapman TR; Strand KA; Fleshner M; Bachtell RK; Somogyi AA; Yin H; Katz JL; Rice KC; Maier SF; Watkins LR
J Neurosci; 2012 Aug; 32(33):11187-200. PubMed ID: 22895704
[TBL] [Abstract][Full Text] [Related]
22. Morphine-3-glucuronide causes antinociceptive cross-tolerance to morphine and increases spinal substance P expression.
Blomqvist KJ; Viisanen H; Ahlström FHG; Jokinen V; Sidorova YA; Suleymanova I; Rauhala PV; Kalso EA; Lilius TO
Eur J Pharmacol; 2020 May; 875():173021. PubMed ID: 32112778
[TBL] [Abstract][Full Text] [Related]
23. A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.
Shah M; Anwar MA; Yesudhas D; Krishnan J; Choi S
Sci Rep; 2016 Dec; 6():39271. PubMed ID: 27982096
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice.
Komatsu T; Sakurada S; Katsuyama S; Sanai K; Sakurada T
Int Rev Neurobiol; 2009; 85():207-19. PubMed ID: 19607972
[TBL] [Abstract][Full Text] [Related]
25. Acute morphine blocks spinal respiratory motor plasticity via long-latency mechanisms that require toll-like receptor 4 signalling.
Tadjalli A; Seven YB; Sharma A; McCurdy CR; Bolser DC; Levitt ES; Mitchell GS
J Physiol; 2021 Aug; 599(15):3771-3797. PubMed ID: 34142718
[TBL] [Abstract][Full Text] [Related]
26. Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.
Antonilli L; Petecchia E; Caprioli D; Badiani A; Nencini P
Psychopharmacology (Berl); 2005 Oct; 182(1):58-64. PubMed ID: 15986196
[TBL] [Abstract][Full Text] [Related]
27. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells.
Merighi S; Gessi S; Varani K; Fazzi D; Stefanelli A; Borea PA
Biochem Pharmacol; 2013 Aug; 86(4):487-96. PubMed ID: 23796752
[TBL] [Abstract][Full Text] [Related]
28. The Role of Opioid Receptors in Immune System Function.
Eisenstein TK
Front Immunol; 2019; 10():2904. PubMed ID: 31921165
[TBL] [Abstract][Full Text] [Related]
29. Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine.
Eidson LN; Murphy AZ
J Neurosci; 2013 Oct; 33(40):15952-63. PubMed ID: 24089500
[TBL] [Abstract][Full Text] [Related]
30. Glial TLR4 signaling does not contribute to opioid-induced depression of respiration.
Zwicker JD; Zhang Y; Ren J; Hutchinson MR; Rice KC; Watkins LR; Greer JJ; Funk GD
J Appl Physiol (1985); 2014 Oct; 117(8):857-68. PubMed ID: 25103966
[TBL] [Abstract][Full Text] [Related]
31. Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.
Ferrari LF; Araldi D; Bogen O; Green PG; Levine JD
Neuroscience; 2019 Feb; 398():64-75. PubMed ID: 30529265
[TBL] [Abstract][Full Text] [Related]
32. Carbamazepine potentiates the effectiveness of morphine in a rodent model of neuropathic pain.
Due MR; Yang XF; Allette YM; Randolph AL; Ripsch MS; Wilson SM; Dustrude ET; Khanna R; White FA
PLoS One; 2014; 9(9):e107399. PubMed ID: 25221944
[TBL] [Abstract][Full Text] [Related]
33. The role of TLR4-mediated PTEN/PI3K/AKT/NF-κB signaling pathway in neuroinflammation in hippocampal neurons.
Zhao M; Zhou A; Xu L; Zhang X
Neuroscience; 2014 Jun; 269():93-101. PubMed ID: 24680857
[TBL] [Abstract][Full Text] [Related]
34. Morphine-3-glucuronide: hyperglycemic and neuroendocrine potentiating effects.
Hashiguchi Y; Molina PE; Abumrad NN
Brain Res; 1995 Oct; 694(1-2):13-20. PubMed ID: 8974636
[TBL] [Abstract][Full Text] [Related]
35. Oxycodone attenuates vascular leak and lung inflammation in a clinically relevant two-hit rat model of acute lung injury.
Li X; Li R; Fang Q; Jamal M; Wang C; Wang Y; Zhang Z; Wu X; Song X
Cytokine; 2021 Feb; 138():155346. PubMed ID: 33187816
[TBL] [Abstract][Full Text] [Related]
36. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
[TBL] [Abstract][Full Text] [Related]
37. Morphine upregulates functional expression of neurokinin-1 receptor in neurons.
Wan Q; Douglas SD; Wang X; Kolson DL; O'Donnell LA; Ho WZ
J Neurosci Res; 2006 Nov; 84(7):1588-96. PubMed ID: 16983662
[TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide and Morphine-3-Glucuronide-Induced Immune Signalling Increases the Expression of Polysialic Acid in PC12 Cells.
Iqbal S; Parker LM; Everest-Dass AV; Moh ESX; Sayyadi N; Hutchinson MR; Packer NH
Mol Neurobiol; 2020 Feb; 57(2):964-975. PubMed ID: 31646464
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats.
Tumati S; Roeske WR; Largent-Milnes TM; Vanderah TW; Varga EV
J Neurosci Methods; 2011 Jul; 199(1):62-8. PubMed ID: 21571003
[TBL] [Abstract][Full Text] [Related]
40. Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains.
Liu L; Coller JK; Watkins LR; Somogyi AA; Hutchinson MR
Brain Behav Immun; 2011 Aug; 25(6):1223-32. PubMed ID: 21447380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
